The pharmaceutical landscape for glucose is shifting, and transdermal GLP-1 delivery systems represent a potential breakthrough. Unlike injections, this technique offers a simpler way to administer GLP-1 drugs. These devices slowly release the medication through the skin offering a consistent lev